Translating Human Genetics into Mouse: the Impact of Ultra-rapid in Vivo Genome Editing
Overview
Reproductive Medicine
Authors
Affiliations
Gene-targeted mutant animals, such as knockout or knockin mice, have dramatically improved our understanding of the functions of genes in vivo and the genetic diversity that characterizes health and disease. However, the generation of targeted mice relies on gene targeting in embryonic stem (ES) cells, which is a time-consuming, laborious, and expensive process. The recent groundbreaking development of several genome editing technologies has enabled the targeted alteration of almost any sequence in any cell or organism. These technologies have now been applied to mouse zygotes (in vivo genome editing), thereby providing new avenues for simple, convenient, and ultra-rapid production of knockout or knockin mice without the need for ES cells. Here, we review recent achievements in the production of gene-targeted mice by in vivo genome editing.
Kang S, Hawkins N, Thompson C, Baker E, Echevarria-Cooper D, Barse L Neurobiol Dis. 2024; 194:106470.
PMID: 38485094 PMC: 11024897. DOI: 10.1016/j.nbd.2024.106470.
Genotyping Protocols for Genetically Engineered Mice.
Limaye A, Cho K, Hall B, Khillan J, Kulkarni A Curr Protoc. 2023; 3(11):e929.
PMID: 37984376 PMC: 10754054. DOI: 10.1002/cpz1.929.
Improved mouse models and advanced genetic and genomic technologies for the study of neutrophils.
Hosur V, Skelly D, Francis C, Low B, Kohar V, Burzenski L Drug Discov Today. 2020; 25(6):1013-1025.
PMID: 32387410 PMC: 7329609. DOI: 10.1016/j.drudis.2020.03.018.
Tan L, Hu Y, Li Y, Yang L, Cai X, Liu W PLoS One. 2020; 15(3):e0230126.
PMID: 32226034 PMC: 7105122. DOI: 10.1371/journal.pone.0230126.
Embryonic Development of the Bicuspid Aortic Valve.
Martin P, Kloesel B, Norris R, Lindsay M, Milan D, Body S J Cardiovasc Dev Dis. 2017; 2(4):248-272.
PMID: 28529942 PMC: 5438177. DOI: 10.3390/jcdd2040248.